New pill for weight loss enters human testing
NCT ID NCT05835752
Summary
This was an early-stage study to check the safety and basic effects of a new oral drug, RAY1225, which is being developed for weight management. It involved 68 healthy and obese adults in China. The main goal was to see how the body processes the drug and to monitor for any side effects, while also measuring initial changes in body weight and waist size.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanfang Hospital,South Medical Hospital
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.